Influence of Hydrogen-Bonding Substituents on the Cytotoxicity of RAPTA Compounds

This publication has 51 references indexed in Scilit:

• A Phase I and Pharmacological Study with Imidazolium- trans- DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent
  Clinical Cancer Research, 2004
• Ruthenium Anticancer Drugs
  Published by Taylor & Francis ,2004
• Kinetics of Aquation and Anation of Ruthenium(II) Arene Anticancer Complexes, Acidity and X‐ray Structures of Aqua Adducts
  Chemistry – A European Journal, 2003
• Recent Developments in the Field of Tumor-Inhibiting Metal Complexes
  Current Pharmaceutical Design, 2003
• Clinical Pharmacokinetics and Administration of Established Platinum Drugs
  Drugs, 2000
• Current Status of Platinum-Based Antitumor Drugs
  Chemical Reviews, 1999
• Non-Platinum Chemotherapeutic Metallopharmaceuticals
  Chemical Reviews, 1999
• Improved understanding in platinium antitumour chemistry
  Chemical Communications, 1996
• Spontaneous aquation reactions of a promising tumor inhibitor trans-imidazolium-tetrachlorobis(imidazole)ruthenium(III), trans-HIm[RuCl4(Im)2]
  Inorganica Chimica Acta, 1995
• Radioruthenium-Labeled Compounds for Diagnostic Tumor Imaging
  Published by Springer Nature ,1989